Results 171 to 180 of about 7,662 (208)

Custo-Beneficio do dabigatrano etexilato na terapêutica antitrombótica na fibrilação auricular [PDF]

, 2013
Lina Sílvia Gouveia Moreira
core  

Recombinant Tissue-type Plasminogen Activator (rt-PA) Therapy in an Acute Stroke Patient Taking Dabigatran Etexilate: A Case Report and Literature Review

, 2014
Emi Tabata, Masahiro Yasaka, Yoshiyuki Wakugawa, Yasushi Okada   +3 more
openalex   +2 more sources

Stability of repackaged dabigatran etexilate capsules in dose administration aids. [PDF]

Eur J Hosp Pharm, 2018
Robertson SG, Glass BD.
europepmc   +1 more source

Design and rationale for the DIVERSITY study: An open-label, randomized study of dabigatran etexilate for pediatric venous thromboembolism. [PDF]

Res Pract Thromb Haemost, 2018
Albisetti M, Biss B, Bomgaars L, Brandão LR, Brueckmann M, Chalmers E, Gropper S, Harper R, Huang F, Luciani M, Manastirski I, Mitchell LG, Tartakovsky I, Wang B, Halton JML.   +14 more
europepmc   +1 more source

Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial.

JAMA Neurol, 2019
Ferro JM, Coutinho JM, Dentali F, Kobayashi A, Alasheev A, Canhão P, Karpov D, Nagel S, Posthuma L, Roriz JM, Caria J, Frässdorf M, Huisman H, Reilly P, Diener HC, RE-SPECT CVT Study Group.   +15 more
europepmc   +1 more source

Anticoagulantia, een veld in beweging [PDF]

, 2010
Christiaens, Thierry, De Backer, Tine
core  

Clinical Economic Analysis of the Use of Enoxaparin, Rivaroxaban and Dabigatran Etexilate for Venous Thromboembolism Prophylaxis (VTP) in Patients after Vast Orthopaedic Operations

, 2016
N. A. Eskin, E. V. Dergach, E. Pyadushkina   +2 more
openalex   +2 more sources

Anticoagulation efficacy of dabigatran etexilate for left atrial appendage thrombus in patients with atrial fibrillation by transthoracic and transesophageal echocardiography. [PDF]

Medicine (Baltimore), 2018
Xing XF, Liu NN, Han YL, Zhou WW, Liang M, Wang ZL.   +5 more
europepmc   +1 more source

Assessing Potential Drug-Drug Interactions Between Dabigatran Etexilate and a P-Glycoprotein Inhibitor in Renal Impairment Populations Using Physiologically Based Pharmacokinetic Modeling. [PDF]

CPT Pharmacometrics Syst Pharmacol, 2019
Doki K, Neuhoff S, Rostami-Hodjegan A, Homma M.   +3 more
europepmc   +1 more source

PCV66 ECONOMIC PERFORMANCE OF DABIGATRAN ETEXILATE FOR PRIMARY VTE PREVENTION FOLLOWING TOTAL HIP AND KNEE REPLACEMENT SURGERY IN ITALY

, 2010
Orietta Zaniolo, Lorenzo Pradelli
openalex   +1 more source